Advanced Cell Diagnostics
AcquiredNewark, United States · Founded 2006
- Headquarters
- Newark, California
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Website
- acdbio.com
- Last Round
- Series CJan 2015
- Rounds
- 1
- Acquired by
- Bio-TechneAug 2016
About
Advanced Cell Diagnostics (ACD) develops and commercializes proprietary consumables for genomic analysis, best known for its RNAscope RNA in-situ hybridization technology, which visualizes gene expression in individual cells while preserving tissue morphology. Founded in 2006 by Dr. Yuling Luo and Dr. Steve Chen, ACD grew to over 100 employees and a catalog of more than 9,000 probe reagents used in thousands of academic and industrial labs. Headquartered in Newark, California with field offices in Italy, China, and Japan, ACD was acquired by Bio-Techne Corporation in 2016 for $250 million plus up to $75 million in contingent consideration.
Summary
Advanced Cell Diagnostics is a Biotech company based in Newark, United States, founded in 2006. Its most recent funding was a Series C round in Jan 2015. Investors include Bio-Techne Corporation and Summit Partners.
Funding History
Aug 2016
Sign up to see all 2 rounds
Series C through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/advanced-cell-diagnostics"><img src="https://indexed.vc/api/badge/company/advanced-cell-diagnostics" alt="Advanced Cell Diagnostics on Indexed.vc" width="260" height="76" /></a>